01:18 PM EDT, 10/29/2025 (MT Newswires) -- European stock markets closed mostly lower in Wednesday trading as Germany's DAX was down 0.64%, France's CAC 40 lost 0.19%, the Stoxx Europe 600 fell 0.1%, the Swiss Market Index slid 0.37%, while the FTSE 100 in London advanced 0.61%.

Spain's quarterly gross domestic product growth slowed to 0.6% in Q3 from 0.8% in the previous three-month period, according to preliminary data from the National Statistics Institute.

And in corporate news, Mercedes-Benz said its Q3 earnings per share fell to 1.22 euros ($1.42) from 1.81 euros and revenue dropped to 32.15 billion euros from 34.53 billion euros a year earlier.

The German automaker was among the top gainers on the DAX, rising over 4%.

Adidas said its Q3 EPS rose to 2.58 euros from 2.48 euros and net sales climbed to 6.63 billion euros from 6.44 billion euros a year earlier.

The German athletic apparel and footwear company led the decliners on the DAX, retreating over 10%.

Deutsche Bank reported Q3 earnings of 0.89 euros per diluted share, up from 0.81 euros a year earlier. Total revenue for the quarter ended Sept. 30 was 8.04 billion euros, up from 7.50 billion euros a year earlier.

The German bank was the top performer on the DAX, increasing almost 5%.

Banco Santander reported Q3 earnings of 0.23 euros per diluted share. Revenue for the quarter ended Sept. 30 was 15.27 billion euros, up from 15.14 billion euros a year earlier. Banco Santander said it is confident it will meet its 2025 targets, including revenue of 62 billion euros and mid-high single-digit net fee income growth.

Shares of the Spanish lender climbed 4% on the Continuous Market in Spain.

UBS Group reported Q3 earnings of $0.76 per diluted share, up from $0.43 a year earlier. Underlying revenue for the quarter ended Sept. 30 was $12.2 billion, compared with $11.67 billion a year earlier.

Shares of the Swiss lender were down 1% in Zurich.

GSK reported Q3 core earnings of 0.55 British pounds ($0.73) per share, up from 0.497 pounds a year earlier. Turnover for the quarter ended Sept. 30 was 8.55 billion pounds, up from 8.01 billion pounds a year earlier. GSK now expects 2025 core EPS to increase 10% to 12%, compared with its previous growth guidance range of 6% to 8%. Full-year turnover is now projected to increase 6% to 7%, compared with GSK's prior expectations for an increase of 3% to 5%.

The British pharmaceutical giant was among the top gainers on the FTSE, rising over 6%.

Equinor reported Q3 adjusted earnings of $0.37 per diluted share, down from $0.79 a year earlier. Revenue for the quarter ended Sept. 30 was $26.05 billion, up from $25.45 billion a year earlier.

Shares of the Norwegian petroleum refiner closed flattish in Oslo.